Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,990 | 82 | 97.8% |
| Education | $65.99 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $923.76 | 13 | $0 (2023) |
| ABBVIE INC. | $281.34 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $266.13 | 8 | $0 (2023) |
| Novo Nordisk Inc | $211.14 | 7 | $0 (2023) |
| Gilead Sciences, Inc. | $208.29 | 13 | $0 (2023) |
| Lilly USA, LLC | $171.84 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $170.79 | 5 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $169.29 | 5 | $0 (2022) |
| Lucid Diagnostics Inc. | $153.89 | 3 | $0 (2022) |
| Esperion Therapeutics, Inc. | $125.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.74 | 9 | Daiichi Sankyo Inc. ($170.79) |
| 2023 | $1,175 | 24 | ABBVIE INC. ($281.34) |
| 2022 | $923.18 | 28 | AstraZeneca Pharmaceuticals LP ($392.22) |
| 2021 | $715.33 | 22 | AstraZeneca Pharmaceuticals LP ($296.38) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardio-renal | ||||||
| 08/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/29/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.61 | General |
| 10/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Biological | ||||||
| 10/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: Biological | ||||||
| 10/16/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Biological | ||||||
| 10/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Biological | ||||||
| 10/03/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.99 | General |
| 09/26/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $123.55 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Biological | ||||||
| 08/22/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.28 | General |
| Category: Biological | ||||||
| 08/18/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.20 | General |
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: Biological | ||||||
| 06/21/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $81.46 | General |
| Category: Respiratory | ||||||
| 05/31/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 64 | 69 | $8,871 | $3,666 |
| 2022 | 4 | 94 | 132 | $26,321 | $6,295 |
| 2021 | 3 | 75 | 86 | $18,877 | $4,995 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,081 | $1,414 | 68.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 31 | $3,988 | $1,127 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $2,362 | $954.02 | 40.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $440.00 | $171.16 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 93 | $17,294 | $3,986 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $3,372 | $1,351 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 15 | $4,215 | $888.36 | 21.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $1,440 | $69.69 | 4.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 40 | $11,079 | $3,074 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 34 | $6,358 | $1,817 | 28.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $1,440 | $103.90 | 7.2% |
About Selina Mendes, PA-C
Selina Mendes, PA-C is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2020. The National Provider Identifier (NPI) number assigned to this provider is 1366049348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Selina Mendes, PA-C has received a total of $3,056 in payments from pharmaceutical and medical device companies, with $242.74 received in 2024. These payments were reported across 83 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,990).
As a Medicare-enrolled provider, Mendes has provided services to 233 Medicare beneficiaries, totaling 287 services with total Medicare billing of $14,957. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Henderson, NV
- Active Since 10/02/2020
- Last Updated 03/15/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366049348
Products in Payments
- FARXIGA (Drug) $494.68
- BREZTRI (Drug) $429.08
- Veozah (Drug) $200.14
- NURTEC ODT (Drug) $196.77
- INJECTAFER (Drug) $170.79
- MOUNJARO (Drug) $153.72
- NEXLIZET (Drug) $125.00
- QULIPTA (Drug) $124.14
- VRAYLAR (Drug) $122.81
- Cologuard Collection Kit (Device) $44.85
- Xofluza (Drug) $42.77
- GARDASIL 9 (Biological) $36.36
- UBRELVY (Drug) $34.39
- Otezla (Drug) $30.21
- Ozempic (Drug) $29.56
- DUPIXENT (Biological) $29.25
- Vascepa (Drug) $29.24
- PREVNAR 13 (Biological) $26.70
- NAPRELAN (Drug) $26.26
- Repatha (Biological) $26.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Anna Liang, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $9,518
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Andrea Alessi, Pa, PA
Physician Assistant — Payments: $6,647
Laurie Michlin, Apn, APN
Physician Assistant — Payments: $6,402